Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Nov;69(5):555–558. doi: 10.1136/adc.69.5.555

Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine.

D B Grant 1, P W Fuggle 1, I Smith 1
PMCID: PMC1029617  PMID: 8257174

Abstract

Plasma thyroid stimulating hormone (TSH) concentrations obtained during the first four years of treatment in 418 children with congenital hypothyroidism, identified by neonatal screening, were examined in relation to paired measurements of plasma thyroxine (n = 1945), free thyroxine (n = 836), triiodothyronine (n = 480), and free triiodothyronine (n = 231), and estimated daily dose of thyroxine at the time of blood sampling. Overall, plasma TSH was above 7 mU/l in 1280 out of 2960 samples (43%); the percentage was not related to severity of hypothyroidism at diagnosis. Mean values for thyroxine and free thyroxine, and to a lesser extent free triiodothyronine, were consistently lower in samples with TSH concentrations over 7 mU/l and this was the case in patients with either severe or less severe hypothyroidism. Raised TSH concentrations were also associated with lower mean doses of thyroxine (micrograms/kg/day) but here the mean doses of thyroxine in children with severe hypothyroidism were higher than in the children with less severe hypothyroidism. The mean dose of thyroxine associated with low/normal TSH values was highest in the first 6 months and fell progressively. Thyroxine dose was significantly related to thyroxine and free thyroxine concentrations but not to triiodothyronine and free triiodothyronine and the latter appeared to be of limited value as measures of plasma thyroid hormone status during treatment.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbassi V., Aldige C. Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr. 1977 Feb;90(2):298–301. doi: 10.1016/s0022-3476(77)80656-2. [DOI] [PubMed] [Google Scholar]
  2. Abusrewil S. S., Tyfield L., Savage D. C. Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child. 1988 Nov;63(11):1368–1371. doi: 10.1136/adc.63.11.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiovato L., Giusti L., Tonacchera M., Ciampi M., Mammoli C., Lippi F., Lapi P., Bargagna S., Dini P., Ferretti G. Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism. J Endocrinol Invest. 1991 Dec;14(11):957–964. doi: 10.1007/BF03347122. [DOI] [PubMed] [Google Scholar]
  4. Frost G. J., Parkin J. M. Management of patients with congenital hypothyroidism. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1485–1489. doi: 10.1136/bmj.290.6480.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Germak J. A., Foley T. P., Jr Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1990 Aug;117(2 Pt 1):211–219. doi: 10.1016/s0022-3476(05)80532-3. [DOI] [PubMed] [Google Scholar]
  6. Grant D. B., Smith I., Fuggle P. W., Tokar S., Chapple J. Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. Arch Dis Child. 1992 Jan;67(1):87–90. doi: 10.1136/adc.67.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grant D. B., Smith I. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) 1988 May 14;296(6633):1355–1358. doi: 10.1136/bmj.296.6633.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Helfand M., Crapo L. M. Monitoring therapy in patients taking levothyroxine. Ann Intern Med. 1990 Sep 15;113(6):450–454. doi: 10.7326/0003-4819-113-6-450. [DOI] [PubMed] [Google Scholar]
  9. Hodges S., O'Malley B. P., Northover B. N., Woods K. L., Swift P. G. Reappraisal of thyroxine treatment in primary hypothyroidism. Arch Dis Child. 1990 Oct;65(10):1129–1132. doi: 10.1136/adc.65.10.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hulse J. A., Grant D. B., Jackson D., Clayton B. E. Growth, development, and reassessment of hypothyroid infants diagnosed by screening. Br Med J (Clin Res Ed) 1982 May 15;284(6327):1435–1437. doi: 10.1136/bmj.284.6327.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Reichlin S., Utiger R. D. Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab. 1967 Feb;27(2):251–255. doi: 10.1210/jcem-27-2-251. [DOI] [PubMed] [Google Scholar]
  12. Rezvani I., DiGeorge A. M. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr. 1977 Feb;90(2):291–297. doi: 10.1016/s0022-3476(77)80655-0. [DOI] [PubMed] [Google Scholar]
  13. Sato T., Suzuki Y., Taketani T., Ishiguro K., Nakajima H. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism. J Clin Endocrinol Metab. 1977 Mar;44(3):553–559. doi: 10.1210/jcem-44-3-553. [DOI] [PubMed] [Google Scholar]
  14. Stall G. M., Harris S., Sokoll L. J., Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990 Aug 15;113(4):265–269. doi: 10.7326/0003-4819-113-4-265. [DOI] [PubMed] [Google Scholar]
  15. Volta C., Ghizzoni L., Davoli A., D'Amato L., Panza C., Bernasconi S. Thyroid function tests in children with congenital hypothyroidism on L-thyroxine treatment. Horm Res. 1989;32(4):109–112. doi: 10.1159/000181270. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES